TY  - CONF

T1  - Nab-Paclitaxel weekly or Q3Wks compared to Docetaxel Q3Wks as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial

JO  - EJC SUPPLEMENTS

PY  - 2007/09/01

AU  - Dranitsaris G

AU  - Coleman R

AU  - Gradishar WJ

ED  - 

VL  - 5

IS  - 4

SP  - 219

EP  - 219

Y2  - 2025/10/10

ER  -